1. Home
  2. REPL vs BV Comparison

REPL vs BV Comparison

Compare REPL & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$22.28

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

N/A

Current Price

$11.79

Market Cap

1.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
REPL
BV
Founded
2015
1939
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
REPL
BV
Price
$22.28
$11.79
Analyst Decision
Buy
Buy
Analyst Count
8
11
Target Price
★ $23.33
$15.35
AVG Volume (30 Days)
★ 3.0M
818.0K
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.21
Revenue Next Year
$513.15
$0.18
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$9.82
52 Week High
$21.91
$15.00

Technical Indicators

Market Signals
Indicator
REPL
BV
Relative Strength Index (RSI) 81.09 62.90
Support Level $7.11 $11.47
Resistance Level N/A $11.82
Average True Range (ATR) 1.43 0.42
MACD 0.90 0.10
Stochastic Oscillator 96.10 75.24

Price Performance

Historical Comparison
REPL
BV

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: